Jones Hill Capital LP — 13F Holdings

2026 Q3  ·  48 Positions

2026 Q3 Portfolio Activity

In 2026 Q3, Jones Hill Capital LP maintained a portfolio of 48 distinct positions. The most significant new addition was BIOCRYST PHARMACEUTICALS INC, now representing 10.01% of the total fund value. They heavily accumulated shares in PHARVARIS N V, increasing the position by 45.7%. Conversely, Jones Hill Capital LP completely exited their position in GILEAD SCIENCES INC.
Position History hover any row below to update
Loading…
PCA Score Concentration Risk
Risk ENB
Total Positions
48
Quarter
2026 Q3
Top Holding
BMRN (11.9%)
Top 10 Concentration
68.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-48 of 48

Jones Hill Capital LP Full Holdings List — 2026 Q3

Stock History Sector / Type Port % Prev % Rank / Prev Conviction
Freshness
Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
BMRN
BIOMARIN PHARMA...
Healthcare 11.93% 17.42% #1
Prev: #1
6.5
—
-259,731 -18.1%
P
S
1,171,859 $70,311,540
$56.57 +3.4%
$60.00 -2.5%
2026 Q1 13F Filing 2026-09-30 2026-11-13
BCRX
BIOCRYST PHARMA...
Healthcare 10.01% — #2
Prev: #—
9.0
—
7,083,300 —
NEW
7,083,300 $59,003,889 2026 Q3 13F Filing 2026-09-30 2026-11-13
TVTX
TRAVERE THERAPE...
Healthcare 9.59% — #3
Prev: #—
8.3
—
959,634 —
NEW
959,634 $56,503,250 2026 Q3 13F Filing 2026-09-30 2026-11-13
INDV
INDIVIOR PHARMA...
Healthcare 9.29% — #4
Prev: #—
7.7
—
1,526,685 —
NEW
1,526,685 $54,731,657 2026 Q3 13F Filing 2026-09-30 2026-11-13
PHVS
PHARVARIS N V
Healthcare 5.32% 4.98% #5 3
Prev: #8
5.1
—
309,758 45.7%
P
S
987,637 $31,327,846 2026 Q1 13F Filing 2026-09-30 2026-11-13
CELC
CELCUITY INC
Healthcare 5.17% — #6
Prev: #—
5.6
—
382,901 —
NEW
382,901 $30,448,288 2026 Q3 13F Filing 2026-09-30 2026-11-13
IONS
IONIS PHARMACEU...
Healthcare 4.55% — #7
Prev: #—
5.3
—
599,826 —
NEW
599,826 $26,782,231 2026 Q3 13F Filing 2026-09-30 2026-11-13
SUPN
SUPERNUS PHARMA...
Healthcare 4.40% — #8
Prev: #—
5.3
—
601,685 —
NEW
601,685 $25,896,522 2026 Q3 13F Filing 2026-09-30 2026-11-13
NUVB
NUVATION BIO IN...
Healthcare 4.26% — #9
Prev: #—
5.2
—
4,486,986 —
NEW
4,486,986 $25,127,122 2026 Q1 13F Filing 2026-09-30 2026-11-13
VERA
VERA THERAPEUTI...
Healthcare 3.57% — #10
Prev: #—
4.9
—
652,218 —
NEW
652,218 $21,060,119 2026 Q3 13F Filing 2026-09-30 2026-11-13
TRVI
TREVI THERAPEUT...
Healthcare 3.52% 5.31% #11 4
Prev: #7
3.4
—
107,944 8.1%
P
S
1,447,156 $20,723,274 2026 Q1 13F Filing 2026-09-30 2026-11-13
BCAX
BICARA THERAPEU...
Healthcare 3.36% 5.63% #12 7
Prev: #5
3.3
—
171,612 19.2%
P
S
1,064,233 $19,805,376 2026 Q1 13F Filing 2026-09-30 2026-11-13
RLMD
RELMADA THERAPE...
Healthcare 3.35% 5.38% #13 7
Prev: #6
3.8
—
1,582,553 43.3%
P
S
5,237,628 $19,745,858 2026 Q1 13F Filing 2026-09-30 2026-11-13
ABVX
ABIVAX SA
Healthcare 2.40% — #14
Prev: #—
4.5
—
142,558 —
NEW
142,558 $14,116,093 2026 Q3 13F Filing 2026-09-30 2026-11-13
ACRS
ACLARIS THERAPE...
Healthcare 2.24% 1.98% #15 1
Prev: #16
3.4
—
745,159 42.4%
P
S
2,504,651 $13,174,464 2026 Q2 13F Filing 2026-09-30 2026-11-13
INSM
INSMED INC
Healthcare 2.06% 2.77% #16 3
Prev: #13
1.3
—
-15,847 -12.9%
P
S
106,528 $12,159,106 2026 Q2 13F Filing 2026-09-30 2026-11-13
NBIX
NEUROCRINE BIOS...
Healthcare 2.01% — #17
Prev: #—
4.3
—
83,426 —
NEW
83,426 $11,833,144 2026 Q3 13F Filing 2026-09-30 2026-11-13
IMCR
IMMUNOCORE HLDG...
Healthcare 1.98% 3.46% #18 7
Prev: #11
0.8
—
-128,578 -25.1%
P
S
384,278 $11,639,781 2026 Q2 13F Filing 2026-09-30 2026-11-13
ERAS
ERASCA INC
Healthcare 1.52% — #19
Prev: #—
4.1
—
610,118 —
NEW
610,118 $8,944,330 2026 Q3 13F Filing 2026-09-30 2026-11-13
CAPR
CAPRICOR THERAP...
Healthcare 1.43% 2.15% #20 5
Prev: #15
3.6
—
471,781 112.1%
P
S
892,532 $8,452,278 2026 Q1 13F Filing 2026-09-30 2026-11-13
DNTH
DIANTHUS THERAP...
Healthcare 1.20% 1.18% #21 3
Prev: #24
3.0
—
22,917 40.1%
P
S
80,017 $7,045,497 2026 Q2 13F Filing 2026-09-30 2026-11-13
NGNE
NEUROGENE INC
Healthcare 1.03% — #22
Prev: #—
3.9
—
217,700 —
NEW
217,700 $6,056,414 2026 Q3 13F Filing 2026-09-30 2026-11-13
CRBP
CORBUS PHARMACE...
Healthcare 1.03% 1.30% #23
Prev: #23
2.9
—
232,856 35.6%
P
S
886,428 $6,045,439 2026 Q2 13F Filing 2026-09-30 2026-11-13
TNXP
TONIX PHARMACEU...
Healthcare 0.93% 1.70% #24 5
Prev: #19
0.9
—
-61,689 -9.9%
P
S
563,739 $5,490,818 2026 Q1 13F Filing 2026-09-30 2026-11-13
SGMT
SAGIMET BIOSCIE...
Healthcare 0.84% — #25
Prev: #—
3.8
—
502,587 —
NEW
502,587 $4,965,560 2026 Q3 13F Filing 2026-09-30 2026-11-13
DYN
DYNE THERAPEUTI...
Healthcare 0.82% — #26
Prev: #—
3.8
—
300,900 —
NEW
300,900 $4,847,499 2026 Q3 13F Filing 2026-09-30 2026-11-13
AVLN
AVALYN PHARMACE...
Healthcare 0.61% — #27
Prev: #—
3.7
—
126,744 —
NEW
126,744 $3,610,937 2026 Q3 13F Filing 2026-09-30 2026-11-13
N/A
ATTOVIA THERAPE...
Unknown 0.53% — #28
Prev: #—
3.7
—
182,295 —
NEW
182,295 $3,124,536 — 13F Filing 2026-09-30 2026-11-13
PHAT
PHATHOM PHARMAC...
Healthcare 0.34% 0.37% #29 1
Prev: #28
3.1
—
115,344 71.4%
P
S
276,830 $2,020,859 2026 Q2 13F Filing 2026-09-30 2026-11-13
LXEO
LEXEO THERAPEUT...
Healthcare 0.34% — #30
Prev: #—
3.6
—
593,737 —
NEW
593,737 $2,006,831 2026 Q3 13F Filing 2026-09-30 2026-11-13
OLMA
OLEMA PHARMACEU...
Healthcare 0.30% 1.53% #31 10
Prev: #21
0.1
—
-367,769 -64.1%
P
S
206,397 $1,783,270 2026 Q2 13F Filing 2026-09-30 2026-11-13
TENX
TENAX THERAPEUT...
Healthcare 0.04% — #32
Prev: #—
3.5
—
122,169 —
NEW
122,169 $230,899 2026 Q3 13F Filing 2026-09-30 2026-11-13
ALVO
ALVOTECH
Healthcare 0.03% — #33
Prev: #—
3.5
—
26,700 —
NEW
26,700 $154,860 2026 Q3 13F Filing 2026-09-30 2026-11-13
ACHV
ACHIEVE LIFE SC...
Healthcare 0.00% 0.04%
Sold All 😨
(Was: #29)
0.0
—
-26,760 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-13
GPCR
STRUCTURE THERA...
Healthcare 0.00% 0.46%
Sold All 😨
(Was: #27)
0.0
—
-40,567 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-13
ELVN
ENLIVEN THERAPE...
Healthcare 0.00% 0.54%
Sold All 😨
(Was: #26)
0.0
—
-49,850 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-13
VRTX
VERTEX PHARMACE...
Healthcare 0.00% 1.17%
Sold All 😨
(Was: #25)
0.0
—
-11,123 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-13
VIR
VIR BIOTECHNOLO...
Healthcare 0.00% 1.43%
Sold All 😨
(Was: #22)
0.0
—
-659,213 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-13
SNDX
SYNDAX PHARMACE...
Healthcare 0.00% 1.58%
Sold All 😨
(Was: #20)
0.0
—
-340,000 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-13
ORIC
ORIC PHARMACEUT...
Healthcare 0.00% 1.72%
Sold All 😨
(Was: #18)
0.0
—
-747,313 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-13
IMUX
IMMUNIC INC
Healthcare 0.00% 1.76%
Sold All 😨
(Was: #17)
0.0
—
-539,814 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-13
NUVL
NUVALENT INC
Healthcare 0.00% 2.58%
Sold All 😨
(Was: #14)
0.0
—
-98,442 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-13
AMLX
AMYLYX PHARMACE...
Healthcare 0.00% 3.41%
Sold All 😨
(Was: #12)
0.0
—
-894,058 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-13
ANIP
ANI PHARMACEUTI...
Healthcare 0.00% 4.11%
Sold All 😨
(Was: #10)
0.0
—
-233,808 -100.0%
CLOSED
— $— 2026 Q1 13F Filing 2026-09-30 2026-11-13
XENE
XENON PHARMACEU...
Healthcare 0.00% 4.72%
Sold All 😨
(Was: #9)
0.0
—
-367,900 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-13
MDGL
MADRIGAL PHARMA...
Healthcare 0.00% 6.00%
Sold All 😨
(Was: #4)
0.0
—
-52,545 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-13
ARQT
ARCUTIS BIOTHER...
Healthcare 0.00% 6.07%
Sold All 😨
(Was: #3)
0.0
—
-1,089,701 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-13
GILD
GILEAD SCIENCES...
Healthcare 0.00% 9.21%
Sold All 😨
(Was: #2)
0.0
—
-343,043 -100.0%
CLOSED
— $— 2026 Q2 13F Filing 2026-09-30 2026-11-13
Showing 1-48 of 48 holdings

Unlock Full Jones Hill Capital LP Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics
Full history →